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LETTERS TO EDITOR 
THE INFLUENCE OF MATCHING IN LIVING-RELATED TRANSPLANTS 
In the report by Sanfilippo, Thacker, and Vaughn (1) of the 
living-donor experience in SEOPF, the impression is given that 
matching accounted for the 9% overall difference at 3 years in 
graft survival with a 2-haplotype match (85%) versus a 0-
haplotype match (74%). When cyclosporine and donor-specific 
transfusion were used in a subgroup of the total experience, the 
figures were reversed (78% survival with good match versus 
86% with poor match). Donor relationship was mentioned in 
the Materials and Methods section suggesting that because 
family genotyping was performed these were all living-related 
donor transplantations. Certainly, the 2-haplotype matches 
must have been mostly with siblings. In the Discussion section, 
the clarification is made for the first time " ... that recipients 
of HLA-identical (2 HM) L-D transplants have a significantly 
reduced risk of graft failure compared with unrelated (O-HM) 
L-D transplants ... ". 
ing counts." Instead, the second message contained in their 
refere~ces 2-4 would be strengthened-namely, that poor 
matchmg c~n be overcome regularly even with nonrelated 
t~ansplantatlln by appropriate techniques of immune modula-
tion. The transplantation literature is replete with controversy 
about the equity (or inequity) of tissue matching as an instru-
me~t of cadaver (unrelated) kidney distribution. Since the 
articles, pro and con, tend to be counted rather than read this 
one is apt to appear inappropriately in the pro-typing col~mnK 
THOMAS E. STARZL 
YUleHI Iw AKI 
Department of Surgery 
University of Pittsburgh Medical School 
Pittsburgh, PennsyluaniG 15213 
If the latter condition existed, we wonder if the sea of detail REFERENCES 
and statistical jargon used in this report has obscured the fact 1. Sanfilippo F, Thacker L, Vaughn WK. Living.donor renal trans. 
that related donors have a biologic advantage over nonrelated plantation in SEOPF. Transplantation 1990; 49: 25. 
donors beyond what can be measured with HLA typing (2). If 2. Cicciarelli J. Living donor kidney transplant.. In: Terasaki PI, ed. 
this were acknowledged, the message would not be that "match- Los Angeles: UCLA Tisaue Typing Laboratory, 1988: 293. 
REPLY TO STARZL AND IWAKI 
The letter by Drs. Starzl and Iwaki raise several issues in 
regard to our recent publication on living-donor renal trans-
plants (J). Indeed, the biologic relationship of donors and 
recipients in the O-haplotype-matched (O-HM) group was not 
defined in this article. Biologic relatives accounted for 71 of the 
115 O-HM recipients (62%), whereas the remainder (38%) were 
unrelated living donors. 
The question of whether related donors have a biologic 
advantage over unrelated donors independent of HLA compat-
ibility cannot be accurately ascertained from the limited data 
available in this study. A simplistic comparison of actuarial 
graft survival between the related versus unrelated O-HM pa-
tients shows no suggested differences at 6 months (85.5 ± 4.3% 
vs. 84.9 ± 5.7%), 1 year (SO.6 ± 4.9% vs. 78.9 ± 6.7%), or 2 
years (72.3 ± 5.9% vs. 75.2 ± 7.3%). However, this apparent 
lack of difference must be qualified by several demographic 
differences between these two groups. For example, compared 
with unrelated O-HM recipients, the related O-HM group in-
cludes a lower percentage of patients more than 45 years old 
and a threefold higher percentage of black patients. In addition, 
a majority of the related O-HM patients were transplanted at 
centers that did not do unrelated 0-HM transplants. Since, age, 
race, and center effects may each independently impact on 
graft survival, these demographic differences must at least be 
considered before drawing any conclusions from unstratified 
univariate comparisons. Unfortunately, the relatively small 
number of patients in these groups precludes meaningful strat-
ification or multivariate analysis to resolve this question. 
The reference cited (2) to suggest that graft survival between 
O-haplotype siblings is better than that of living-nonrelated 
patients also presents a simple univariate comparison of graft 
survival that shows that the suggested difference is not statis-
tically significant. Moreover, the difference observed might be 
explained by demographic differences between these groups for 
race, donor age, or immunosuppressive therapy. A critical ex-
amination of this question using an appropriate patient study 
population remains to be done, and would provide an answer 
to the very important question raised 
Finally, we share the hope that this article will be read rather 
than counted, so that our detailed analysis can be critically 
evaluated and understood We think our findings clearly sup-
port the conclusions that are summarized in the last paragraph 
of the Discussion section and the last sentence of the Abstract-
i.e., "that the use of pretransplant transfusions and CsA therapy 
may have differential benefits depending upon HM [haplotype 
matching] in living-donor renal transplantation." 
FRED SANFILIPPO 
WILLIAM K. VAUGHN 
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